Here, we also confirmed that the mean percentage of CD26+ CML LSCs in resistant patients was lower compared to newly diagnosed patients but CD26+ cells were still detectable in both stem/progenitor cells population. Here, DPP4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.